{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:19:53Z","timestamp":1791778793433,"version":"4.3.4"},"reference-count":165,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.4065\/79.4.504","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:23:48Z","timestamp":1232760228000},"page":"504-522","source":"Crossref","is-referenced-by-count":146,"title":["Management of Immune Thrombocytopenic Purpura in Adults"],"prefix":"10.4065","volume":"79","author":[{"given":"Roberto","family":"Stasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Provan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/79.4.504_bib1","series-title":"Williams Hematology","first-page":"1315","article-title":"Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms","author":"George","year":"1995"},{"key":"10.4065\/79.4.504_bib2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.V94.3.909.415k02_909_913","article-title":"The incidence of idiopathic thrombocytopenic purpura in adults increases with age","volume":"94","author":"Frederiksen","year":"1999","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","article-title":"Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients","volume":"122","author":"Neylon","year":"2003","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","author":"British Committee for Standards in Haematology General Haematology Task Force","year":"2003","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1067\/mpd.2000.110123","article-title":"The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment","volume":"137","author":"Dickerhoff","year":"2000","journal-title":"J Pediatr"},{"key":"10.4065\/79.4.504_bib7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(01)07219-1","article-title":"Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study","volume":"358","author":"Kuhne","year":"2001","journal-title":"Lancet"},{"key":"10.4065\/79.4.504_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","article-title":"Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"1995","journal-title":"Am J Med"},{"key":"10.4065\/79.4.504_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V77.1.31.31","article-title":"High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura","volume":"77","author":"Cortelazzo","year":"1991","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib10","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","article-title":"Morbidity and mortality in adults with idiopathic thrombocytopenic purpura","volume":"97","author":"Portielje","year":"2001","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib11","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.4065\/79.4.504_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ajh.2830460212","article-title":"Mortality in immune thrombocytopenic purpura: report of seven cases and consideration of prognostic indicators","volume":"46","author":"Schattner","year":"1994","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.504_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0028-1086135","article-title":"Management of idiopathic thrombocytopenic purpura in the adult","volume":"3","author":"Lacey","year":"1977","journal-title":"Semin Thromb Hemost"},{"key":"10.4065\/79.4.504_bib14","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V91.10.3601","article-title":"Safety and cost effectiveness of a 10 \u00d7 109\/L trigger for prophylactic platelet transfusions compared with the traditional 20 \u00d7 109\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia","volume":"91","author":"Wandt","year":"1998","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM197207272870401","article-title":"The bleeding time as a screening test for evaluation of platelet function","volume":"287","author":"Harker","year":"1972","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood.V83.1.161.161","article-title":"Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression","volume":"83","author":"Peng","year":"1994","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJM197203232861202","article-title":"Qualitative platelet abnormalities in idiopathic thrombocytopenic purpura","volume":"286","author":"Clancy","year":"1972","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0609.1991.tb00529.x","article-title":"Influences of antiplatelet autoantibodies on platelet function in immune thrombocytopenic purpura","volume":"46","author":"Yanabu","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.4065\/79.4.504_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0038-1656350","article-title":"Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa","volume":"68","author":"Balduini","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.4065\/79.4.504_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajh.2830410118","article-title":"Immune Bernard Soulier-like syndrome associated with anti-glycoprotein-IX antibody [letter]","volume":"41","author":"Varon","year":"1992","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.504_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.1990.tb02592.x","article-title":"Platelet aggregating IgG antibody to platelet surface glycoproteins associated with thrombosis and thrombocytopenia","volume":"74","author":"Pfueller","year":"1990","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0002-9343(86)90664-9","article-title":"Efficacy of platelet transfusions in immune thrombocytopenia","volume":"80","author":"Carr","year":"1986","journal-title":"Am J Med"},{"key":"10.4065\/79.4.504_bib23","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1001\/archinte.1989.00390090039008","article-title":"Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid","volume":"149","author":"Bartholomew","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.4065\/79.4.504_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00000441-198712000-00010","article-title":"The role of apheresis in the support of life-threatening ITP relapse","volume":"294","author":"Flick","year":"1987","journal-title":"Am J Med Sci"},{"key":"10.4065\/79.4.504_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJMoa030254","article-title":"Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone","volume":"349","author":"Cheng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V64.6.1179.1179","article-title":"Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American Group on Hemostasis and Thrombosis","volume":"64","author":"Pizzuto","year":"1984","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib27","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V89.8.2689","article-title":"Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients","volume":"89","author":"Scaradavou","year":"1997","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2141.2001.02627.x","article-title":"A dose of 75 microg\/kg\/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg\/kg\/d in adults with immune thrombocytopenic purpura","volume":"112","author":"Newman","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib29","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood.V99.6.1922","article-title":"Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?","volume":"99","author":"Cooper","year":"2002","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00277-002-0461-8","article-title":"Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses","volume":"81","author":"Kumar","year":"2002","journal-title":"Ann Hematol"},{"key":"10.4065\/79.4.504_bib31","first-page":"565","article-title":"Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura","volume":"183","author":"Winde","year":"1996","journal-title":"J Am Coll Surg"},{"key":"10.4065\/79.4.504_bib32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.1999.01766.x","article-title":"Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g\/kg b.w.","volume":"107","author":"Godeau","year":"1999","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4049\/jimmunol.132.2.745","article-title":"Modulation of mononuclear phagocyte function by intravenous gamma-globulin","volume":"132","author":"Kimberly","year":"1984","journal-title":"J Immunol"},{"key":"10.4065\/79.4.504_bib34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00277-002-0488-x","article-title":"Overview of 321 patients with idiopathic thrombocytopenic purpura: retrospective analysis of the clinical features and response to therapy","volume":"81","author":"Pamuk","year":"2002","journal-title":"Ann Hematol"},{"key":"10.4065\/79.4.504_bib35","first-page":"182","article-title":"Splenectomy in idiopathic thrombocytopenic purpura: its correlation with the sequestration of autologous indium-111-labeled platelets","volume":"34","author":"Lamy","year":"1993","journal-title":"J Nucl Med"},{"key":"10.4065\/79.4.504_bib36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.2001.02615.x","article-title":"Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura","volume":"112","author":"Fabris","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0609.1983.tb00662.x","article-title":"High dose intravenous IgG reduces platelet associated immunoglobulins and complement in idiopathic thrombocytopenic purpura","volume":"31","author":"Winiarski","year":"1983","journal-title":"Scand J Haematol"},{"key":"10.4065\/79.4.504_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","article-title":"Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial","volume":"359","author":"Godeau","year":"2002","journal-title":"Lancet"},{"issue":"1, suppl 1","key":"10.4065\/79.4.504_bib39","first-page":"14","article-title":"Anti-D: mechanisms of action","volume":"35","author":"Ware","year":"1998","journal-title":"Semin Hematol"},{"key":"10.4065\/79.4.504_bib40","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood.V77.9.1884.1884","article-title":"Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect","volume":"77","author":"Bussel","year":"1991","journal-title":"Blood"},{"issue":"1, suppl 1","key":"10.4065\/79.4.504_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0037-1963(00)90114-8","article-title":"Long-term outcome of splenectomy for idiopathic thrombocytopenic purpura","volume":"37","author":"Bell","year":"2000","journal-title":"Semin Hematol"},{"key":"10.4065\/79.4.504_bib42","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V71.4.1165.1165","article-title":"Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults","volume":"71","author":"Bellucci","year":"1988","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib43","first-page":"329","article-title":"Treatment of idiopathic thrombocytopenic purpura (ITP): results of a multicentric protocol","volume":"70","author":"Mazzucconi","year":"1985","journal-title":"Haematologica"},{"key":"10.4065\/79.4.504_bib44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2141.1998.01096.x","article-title":"Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura","volume":"103","author":"Alpdogan","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0002-9343(80)90016-9","article-title":"Adult idiopathic thrombocytopenic purpura: clinical findings and response to therapy","volume":"69","author":"DiFino","year":"1980","journal-title":"Am J Med"},{"key":"10.4065\/79.4.504_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000441-198807000-00004","article-title":"Idiopathic thrombocytopenic purpura in the older adult patient","volume":"296","author":"Guthrie","year":"1988","journal-title":"Am J Med Sci"},{"key":"10.4065\/79.4.504_bib47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomized, controlled study","volume":"119","author":"Laan","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.504_bib48","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM198904133201505","article-title":"Mechanisms of response to treatment in autoimmune thrombocytopenic purpura","volume":"320","author":"Gernsheimer","year":"1989","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib49","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1182\/blood.V81.11.2872.2872","article-title":"The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura","volume":"81","author":"Fujisawa","year":"1993","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood.V67.1.203.203","article-title":"Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration","volume":"67","author":"Kitchens","year":"1986","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1423-0410.1987.tb03029.x","article-title":"Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature","volume":"52","author":"Bussel","year":"1987","journal-title":"Vox Sang"},{"key":"10.4065\/79.4.504_bib52","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/jama.1983.03330370058033","article-title":"High-dose intravenous immunoglobulin therapy in patients with immune thrombocytopenic purpura","volume":"249","author":"Carroll","year":"1983","journal-title":"JAMA"},{"key":"10.4065\/79.4.504_bib53","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V82.5.1415.bloodjournal8251415","article-title":"Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin","volume":"82","author":"Godeau","year":"1993","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0887-7963(89)70072-9","article-title":"Use of intravenous gammaglobulin as an immune replacement and an immune suppressant","volume":"3","author":"Boshkov","year":"1989","journal-title":"Transfus Med Rev"},{"key":"10.4065\/79.4.504_bib55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)92205-5","article-title":"Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura","volume":"344","author":"Blanchette","year":"1994","journal-title":"Lancet"},{"key":"10.4065\/79.4.504_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-3476(97)70355-X","article-title":"Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G","volume":"130","author":"Kattamis","year":"1997","journal-title":"J Pediatr"},{"key":"10.4065\/79.4.504_bib57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-121-4-199408150-00004","article-title":"Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors","volume":"121","author":"Sekul","year":"1994","journal-title":"Ann Intern Med"},{"issue":"6, suppl 2","key":"10.4065\/79.4.504_bib58","first-page":"35","article-title":"Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature","volume":"78","author":"Schiavotto","year":"1993","journal-title":"Haematologica"},{"key":"10.4065\/79.4.504_bib59","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.V8111788","article-title":"Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature","volume":"8","author":"Cayco","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.4065\/79.4.504_bib60","first-page":"518","article-title":"Renal insufficiency and failure associated with immune globulin intravenous therapy\u2014United States, 1985-1998","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.4065\/79.4.504_bib61","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2001.02742.x","article-title":"Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy","volume":"113","author":"Sati","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.1988.tb04178.x","article-title":"Effect of commercial immunoglobulin G preparation on human monocyte Fc-receptor dependent binding of antibody coated platelets","volume":"68","author":"Saleh","year":"1988","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2141.1985.tb07417.x","article-title":"Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura","volume":"60","author":"Delfraissy","year":"1985","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib64","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/blood.V74.7.2414.2414","article-title":"Inhibition of auto-antibody binding to platelet glycoprotein IIb\/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin","volume":"74","author":"Berchtold","year":"1989","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib65","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.10253","article-title":"Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)","volume":"72","author":"Schwartz","year":"2003","journal-title":"Am J Hematol"},{"issue":"6, suppl 2","key":"10.4065\/79.4.504_bib66","first-page":"22","article-title":"Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases","volume":"78","author":"Schiavotto","year":"1993","journal-title":"Haematologica"},{"key":"10.4065\/79.4.504_bib67","first-page":"504","article-title":"Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients","volume":"86","author":"Vianelli","year":"2001","journal-title":"Haematologica"},{"key":"10.4065\/79.4.504_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000204251","article-title":"Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura","volume":"91","author":"Ben-Yehuda","year":"1994","journal-title":"Acta Haematol"},{"key":"10.4065\/79.4.504_bib69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00000658-198710000-00014","article-title":"Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP): current criteria for patient selection and results","volume":"206","author":"Akwari","year":"1987","journal-title":"Ann Surg"},{"key":"10.4065\/79.4.504_bib70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000205407","article-title":"Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation","volume":"81","author":"Fabris","year":"1989","journal-title":"Acta Haematol"},{"key":"10.4065\/79.4.504_bib71","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1365-2141.1999.01464.x","article-title":"The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura","volume":"105","author":"Ruivard","year":"1999","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib72","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2141.1997.832723.x","article-title":"The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies","volume":"97","author":"Najean","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib73","first-page":"1040","article-title":"Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpura","volume":"85","author":"Radaelli","year":"2000","journal-title":"Haematologica"},{"key":"10.4065\/79.4.504_bib74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0609.1989.tb00109.x","article-title":"Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): a report on 181 cases","volume":"42","author":"Fenaux","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.4065\/79.4.504_bib75","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000204523","article-title":"Results of splenectomy for idiopathic thrombocytopenic purpura: review of 72 cases","volume":"89","author":"Naouri","year":"1993","journal-title":"Acta Haematol"},{"key":"10.4065\/79.4.504_bib76","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.thj.6200170","article-title":"Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment","volume":"3","author":"Rossi","year":"2002","journal-title":"Hematol J"},{"key":"10.4065\/79.4.504_bib77","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199705223362104","article-title":"High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura","volume":"336","author":"Law","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajh.1072","article-title":"Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?","volume":"67","author":"Bussel","year":"2001","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.504_bib79","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0609.1998.tb01087.x","article-title":"High-dose intravenous immune globulin and the response to splenectomy monitoring with platelet-associated IgG in patients with idiopathic thrombocytopenic purpura [letter]","volume":"61","author":"Kondo","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.4065\/79.4.504_bib80","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/jpsu.2000.6938","article-title":"The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin","volume":"35","author":"Hemmila","year":"2000","journal-title":"J Pediatr Surg"},{"key":"10.4065\/79.4.504_bib81","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/1096-8652(200103)66:3<197::AID-AJH1044>3.0.CO;2-6","article-title":"Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients","volume":"66","author":"Choi","year":"2001","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.504_bib82","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJM199710093371515","article-title":"High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura [letter]","volume":"337","author":"Schneider","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib83","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.1983.tb07307.x","article-title":"Platelet antibody levels do not correlate with response to therapy in idiopathic thrombocytopenic purpura","volume":"53","author":"Kernoff","year":"1983","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-122-3-199502010-00005","article-title":"Estimating the risk for sepsis after splenectomy in hereditary spherocytosis","volume":"122","author":"Schilling","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.504_bib85","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","article-title":"Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen","volume":"2","author":"Davies","year":"2002","journal-title":"Clin Med"},{"key":"10.4065\/79.4.504_bib86","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0039-6109(05)70225-5","article-title":"Laparoscopic splenectomy","volume":"80","author":"Katkhouda","year":"2000","journal-title":"Surg Clin North Am"},{"key":"10.4065\/79.4.504_bib87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1067\/msy.2003.204","article-title":"Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura: clinical and economic analysis","volume":"134","author":"Cordera","year":"2003","journal-title":"Surgery"},{"key":"10.4065\/79.4.504_bib88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00464-002-8805-y","article-title":"Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP)","volume":"17","author":"Pace","year":"2003","journal-title":"Surg Endosc"},{"key":"10.4065\/79.4.504_bib89","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s004640080095","article-title":"Laparoscopic splenectomy","volume":"16","author":"Brodsky","year":"2002","journal-title":"Surg Endosc"},{"key":"10.4065\/79.4.504_bib90","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00268-001-0190-5","article-title":"Laparoscopic splenectomy for idiopathic thrombocytopenic purpura: outcome and long-term results","volume":"26","author":"Bresler","year":"2002","journal-title":"World J Surg"},{"issue":"12, pt 1","key":"10.4065\/79.4.504_bib91","doi-asserted-by":"crossref","first-page":"977","DOI":"10.7326\/0003-4819-116-12-977","article-title":"Splenic radiation for corticosteroid-resistant immune thrombocytopenia","volume":"116","author":"Calverley","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.504_bib92","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.1995.tb05271.x","article-title":"Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomy","volume":"91","author":"Caulier","year":"1995","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2214\/ajr.163.1.8010197","article-title":"Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"163","author":"Miyazaki","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"10.4065\/79.4.504_bib94","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2214\/ajr.179.5.1791323","article-title":"Long-term results of initial and repeated partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"179","author":"Kimura","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.4065\/79.4.504_bib95","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-2141.1998.01120.x","article-title":"Complete splenic embolization in the treatment of immune thrombocytopenic purpura [letter]","volume":"103","author":"Martinez Lagares","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-136-1-200201010-00006","article-title":"Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial","volume":"136","author":"van Everdingen","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.504_bib97","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1365-2141.2002.03669.x","article-title":"Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory ITP in adults","volume":"118","author":"Provan","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib98","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood-2003-03-0900","article-title":"Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura?","volume":"103","author":"Michel","year":"2004","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib99","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1365-2141.2001.03194.x","article-title":"Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura","volume":"115","author":"Jarque","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib100","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib101","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM199406023302203","article-title":"Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy [published correction appears in N Engl J Med. 1994;331:283]","volume":"330","author":"Andersen","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib102","first-page":"491","article-title":"High-dose dexamethasone in adult refractory idiopathic thrombocytopenic purpura [letter]","volume":"93","author":"Schiavotto","year":"1996","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib103","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJM199708073370612","article-title":"High-dose pulsed dexamethasone for immune thrombocytopenia [letter]","volume":"337","author":"Demiroglu","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib104","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/bcmd.2000.0336","article-title":"Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura","volume":"26","author":"Stasi","year":"2000","journal-title":"Blood Cells Mol Dis"},{"key":"10.4065\/79.4.504_bib105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.1995.tb05326.x","article-title":"Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 cases","volume":"91","author":"Caulier","year":"1995","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib106","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0140-6736(91)93379-N","article-title":"Megadose methylprednisolone pulse therapy in adult idiopathic thrombocytopenic purpura [letter]","volume":"337","author":"Akoglu","year":"1991","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.4065\/79.4.504_bib107","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03165102","article-title":"Idiopathic thrombocytopenic purpura: pathophysiology and management","volume":"76","author":"Ahn","year":"2002","journal-title":"Int J Hematol"},{"key":"10.4065\/79.4.504_bib108","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.2830500306","article-title":"Danazol distribution in plasma and cell membranes as related to altered cell properties: implications for mechanism","volume":"50","author":"Horstman","year":"1995","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.504_bib109","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003495-198019050-00001","article-title":"Pharmacology and pharmacokinetics of danazol","volume":"19","author":"Potts","year":"1980","journal-title":"Drugs"},{"key":"10.4065\/79.4.504_bib110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-107-2-177","article-title":"Low-dose danazol therapy in idiopathic thrombocytopenic purpura","volume":"107","author":"Ahn","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.504_bib111","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJM198702263160903","article-title":"Effect of danazol in immune thrombocytopenic purpura","volume":"316","author":"Schreiber","year":"1987","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib112","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7326\/0003-4819-93-6-809","article-title":"Long-term therapy of hereditary angioedema with danazol","volume":"93","author":"Hosea","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.504_bib113","series-title":"The Chemotherapy Sourcebook","first-page":"689","article-title":"Second malignancies after chemotherapy","author":"Kyle","year":"1992"},{"key":"10.4065\/79.4.504_bib114","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.2830010111","article-title":"Treatment of refractory thrombocytopenic purpura with cyclophosphamide","volume":"1","author":"Verlin","year":"1976","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.504_bib115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood.V85.2.351.351","article-title":"Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura","volume":"85","author":"Reiner","year":"1995","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib116","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2141.1994.tb04810.x","article-title":"A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients","volume":"86","author":"Facon","year":"1994","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib117","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJM199304293281703","article-title":"Combination chemotherapy in refractory immune thrombocytopenic purpura","volume":"328","author":"Figueroa","year":"1993","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib118","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJM200105033441815","article-title":"Long-term outcomes after treatment for refractory immune thrombocytopenic purpura [letter]","volume":"344","author":"McMillan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib119","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1182\/blood.V99.4.1482","article-title":"Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura","volume":"99","author":"Emilia","year":"2002","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2141.2001.02893.x","article-title":"Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy","volume":"114","author":"Kappers-Klunne","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib121","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib122","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1600-0609.2002.02686.x","article-title":"Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study","volume":"69","author":"Giagounidis","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.4065\/79.4.504_bib123","first-page":"538","article-title":"B-cell compartment as the selective target for the treatment of immune thrombocytopenias","volume":"88","author":"Zaja","year":"2003","journal-title":"Haematologica"},{"key":"10.4065\/79.4.504_bib124","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2141.1993.tb03117.x","article-title":"CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura","volume":"84","author":"Lim","year":"1993","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2141.2001.03039.x","article-title":"The effect of treatment with Campath-1H in patients with autoimmune cytopenias","volume":"114","author":"Willis","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2001-12-0171","article-title":"High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia","volume":"101","author":"Huhn","year":"2003","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib127","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence of both impaired platelet production and increased platelet clearance","volume":"80","author":"Ballem","year":"1987","journal-title":"J Clin Invest"},{"key":"10.4065\/79.4.504_bib128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1182\/blood.V100.2.728","article-title":"Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura","volume":"100","author":"Nomura","year":"2002","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2141.1995.tb05179.x","article-title":"Dapsone for refractory chronic idiopathic thrombocytopenic purpura","volume":"90","author":"Hernandez","year":"1995","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ajh.2830440117","article-title":"Dapsone for autoimmune thrombocytopenic purpura","volume":"44","author":"Godeau","year":"1993","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.504_bib131","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1182\/blood.V74.6.1894.1894","article-title":"Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon","volume":"74","author":"Proctor","year":"1989","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib132","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0609.1994.tb00651.x","article-title":"Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP)","volume":"52","author":"Dubbeld","year":"1994","journal-title":"Eur J Haematol"},{"issue":"1, suppl 1","key":"10.4065\/79.4.504_bib133","first-page":"36","article-title":"Management of chronic immune thrombocytopenic purpura in children and adults","volume":"35","author":"Blanchette","year":"1998","journal-title":"Semin Hematol"},{"key":"10.4065\/79.4.504_bib134","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.1990.tb02668.x","article-title":"Treatment of chronic autoimmune thrombocytopenic purpura with ascorbate [letter]","volume":"75","author":"Godeau","year":"1990","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(95)91269-X","article-title":"Thrombocytopoietic effect of heparin given in chronic immune thrombocytopenic purpura","volume":"346","author":"Shen","year":"1995","journal-title":"Lancet"},{"key":"10.4065\/79.4.504_bib136","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1365-2141.2002.03430.x","article-title":"Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura","volume":"117","author":"Howard","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib137","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1034\/j.1600-0609.2003.00076.x","article-title":"Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura","volume":"70","author":"Hou","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.4065\/79.4.504_bib138","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood.V81.12.3484.3484","article-title":"2-Chlorodeoxyadenosine in the treatment of chronic refractory immune thrombocytopenic purpura [letter]","volume":"81","author":"Figueroa","year":"1993","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib139","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<85::AID-AJH16>3.0.CO;2-8","article-title":"Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin","volume":"57","author":"Cosgriff","year":"1998","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.504_bib140","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V79.9.2237.2237","article-title":"Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura","volume":"79","author":"Snyder","year":"1992","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib141","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(94)90843-5","article-title":"Severe adverse effects of protein A immunoadsorption [letter]","volume":"343","author":"Kabisch","year":"1994","journal-title":"Lancet"},{"key":"10.4065\/79.4.504_bib142","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2141.1998.00568.x","article-title":"Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit","volume":"100","author":"Cahill","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib143","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajh.10331","article-title":"Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept","volume":"73","author":"McMinn","year":"2003","journal-title":"Am J Hematol"},{"issue":"pt 1","key":"10.4065\/79.4.504_bib144","first-page":"251a","article-title":"A proof-of-concept phase 2 study of monoclonal antibody MDX-33 in adult subjects with chronic stable ITP [abstract]","volume":"96","author":"Terjanian","year":"2000","journal-title":"Blood"},{"issue":"suppl 1, pt 1","key":"10.4065\/79.4.504_bib145","first-page":"646a","article-title":"Humanized monoclonal anti-CD40 ligand antibody (hu5c8) rescue therapy of 15 adults with severe chronic refractory ITP [abstract]","volume":"94","author":"Bussel","year":"1999","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib146","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood-2002-07-2157","article-title":"Suppression of autoreactive T-cell response to glycoprotein IIb\/IIIa by blockade of CD40\/CD154 interaction: implications for treatment of immune thrombocytopenic purpura","volume":"101","author":"Kuwana","year":"2003","journal-title":"Blood"},{"key":"10.4065\/79.4.504_bib147","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00063030-200115110-00005","article-title":"Daclizumab: a review of its use in the management of organ transplantation","volume":"15","author":"Carswell","year":"2001","journal-title":"BioDrugs"},{"key":"10.4065\/79.4.504_bib148","first-page":"177","article-title":"Clinical pharmacology of immunosuppressive drugs: year 2000\u2014time for alternatives","volume":"55","author":"Billaud","year":"2000","journal-title":"Therapie"},{"key":"10.4065\/79.4.504_bib149","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00126839-199901010-00020","article-title":"Promising new agents in the prevention of transplant rejection","volume":"1","author":"Ponticelli","year":"1999","journal-title":"Drugs R D"},{"key":"10.4065\/79.4.504_bib150","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1592\/phco.19.15.1127.30582","article-title":"A review of interleukin-2 receptor antagonists in solid organ transplantation","volume":"19","author":"Berard","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.4065\/79.4.504_bib151","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J Clin Invest"},{"key":"10.4065\/79.4.504_bib152","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM198807213190304","article-title":"Incidentally detected thrombocytopenia in healthy mothers and their infants","volume":"319","author":"Burrows","year":"1988","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.504_bib153","series-title":"Haemostasis and Thrombosis in Obstetrics and Gynaecology","first-page":"407","article-title":"Thrombocytopenia during pregnancy","author":"Burrows","year":"1992"},{"key":"10.4065\/79.4.504_bib154","first-page":"21","article-title":"Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia","volume":"95","author":"Letsky","year":"1996","journal-title":"Br J Haematol"},{"issue":"4, pt 1","key":"10.4065\/79.4.504_bib155","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/0002-9378(90)90674-V","article-title":"Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia","volume":"163","author":"Nicolini","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.4065\/79.4.504_bib156","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0016-5085(90)91027-4","article-title":"Safety of azathioprine in pregnancy in inflammatory bowel disease","volume":"99","author":"Alstead","year":"1990","journal-title":"Gastroenterology"},{"key":"10.4065\/79.4.504_bib157","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2141.2003.04567.x","article-title":"Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy","volume":"123","author":"Michel","year":"2003","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib158","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s002770050391","article-title":"Risk factors for neonatal thrombocytopenia in pregnancy complicated by idiopathic thrombocytopenic purpura","volume":"76","author":"Yamada","year":"1998","journal-title":"Ann Hematol"},{"key":"10.4065\/79.4.504_bib159","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/08880019709041596","article-title":"Thrombocytopenia in neonates born to women with autoimmune thrombocytopenic purpura","volume":"14","author":"Iyori","year":"1997","journal-title":"Pediatr Hematol Oncol"},{"issue":"4, pt 1","key":"10.4065\/79.4.504_bib160","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0029-7844(97)00349-9","article-title":"Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura","volume":"90","author":"Christiaens","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.4065\/79.4.504_bib161","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0002-9378(97)70454-X","article-title":"Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia","volume":"177","author":"Payne","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.4065\/79.4.504_bib162","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00006254-199312000-00003","article-title":"Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery","volume":"48","author":"Burrows","year":"1993","journal-title":"Obstet Gynecol Surv"},{"key":"10.4065\/79.4.504_bib163","first-page":"578","article-title":"Immune thrombocytopenic purpura in pregnancy: a reappraisal of management","volume":"78","author":"Cook","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.4065\/79.4.504_bib164","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2141.1998.01006.x","article-title":"Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia","volume":"103","author":"Valat","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.504_bib165","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199311113292005","article-title":"Fetal thrombocytopenia and its relation to maternal thrombocytopenia","volume":"329","author":"Burrows","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611627687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611627687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:58:56Z","timestamp":1684868336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611627687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":165,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0025619611627687"],"URL":"https:\/\/doi.org\/10.4065\/79.4.504","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}